DHCR7 (NM_001360) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC200480L2V

  • LentiORF®

Lenti ORF particles, DHCR7 (mGFP-tagged) - Human 7-dehydrocholesterol reductase (DHCR7), transcript variant 1, 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP



Need custom lentivirus service?
Get a free quote

CNY 9,975.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-DHCR7 Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00


Lenti ORF control particles of pLenti-C-mGFP, >10^7 TU/mL, 0.5 mL
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00

Specifications

Product Data
Product Name DHCR7 (NM_001360) Human Tagged ORF Clone Lentiviral Particle
Synonyms SLOS
Vector pLenti-C-mGFP
ACCN NM_001360
ORF Size 1425 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC200480).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_001360.2
RefSeq Size 2665 bp
RefSeq ORF 1428 bp
Locus ID 1717
Domains ERG4_ERG24
Protein Families Druggable Genome, Transmembrane
Protein Pathways Metabolic pathways, Steroid biosynthesis
MW 54.5 kDa
Gene Summary This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Aug 2009]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...